[HTML][HTML] Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis: a case report and …
Y Li, J Lin, C Peng - Medicine, 2016 - journals.lww.com
Interventions: Direct factor Xa (FXa) inhibitor rivaroxaban (20 mg/d) was started for the
patient. After 3 weeks of rivaroxaban treatment TEE showed a relevantly decreased …
patient. After 3 weeks of rivaroxaban treatment TEE showed a relevantly decreased …
Real life dabigatran and metabolite concentrations, focused on inter-patient variability and assay differences in patients with atrial fibrillation
K Boonen, E Schmitz, F Rozestraten… - Clinical Chemistry and …, 2017 - degruyter.com
Background: Dabigatran is prescribed to increasing numbers of patients with atrial fibrillation
(AF). Although routine monitoring is not considered to be useful, measuring drug …
(AF). Although routine monitoring is not considered to be useful, measuring drug …
Successful implantation of leadless pacemakers in children: a case series
E Jędrzejczyk-Patej, A Woźniak, L Litwin… - … Heart Journal-Case …, 2020 - academic.oup.com
Background For relief of cold symptoms, methylephedrine is considered to be safer than
ephedrine, particularly when used at the predetermined dose. It is often present in various …
ephedrine, particularly when used at the predetermined dose. It is often present in various …
[HTML][HTML] Massive left atrial thrombi during dabigatran therapy for nonvalvular atrial fibrillation
V Bachvarova, C Bucci, N Ho, P Yazdan-Ashoori… - Case, 2017 - Elsevier
Highlights•Massive LA thrombus is rare in the absence of anticoagulation and mitral
stenosis.•Direct-acting oral anticoagulants are widely used in nonvalvular AF.•Inadequate …
stenosis.•Direct-acting oral anticoagulants are widely used in nonvalvular AF.•Inadequate …
[PDF][PDF] Left atrial appendage thrombus on full-dose dabigatran treatment: a case report
P Candelaresi, A Iannuzzi, G Servillo… - … Heart Journal-Case …, 2020 - academic.oup.com
Background Dabigatran is a direct competitive thrombin inhibitor approved for stroke
prevention in non-valvular atrial fibrillation. At full-dose, dabigatran showed similar rates of …
prevention in non-valvular atrial fibrillation. At full-dose, dabigatran showed similar rates of …
ダビガトラン投与下に巨大左房内遊離血栓を認めた1 例
佐藤俊， 仁科健， 矢田匡， 上田裕一… - 日本心臓血管外科学会 …, 2020 - jstage.jst.go.jp
抄録 症例は 77 歳の女性. 60 歳代より非弁膜症性心房細動 (non valvular atrial fibrillation;
NVAF) に対してワルファリンで抗凝固療法を施行されていた. 1 年半前に心原性脳塞栓症を発症し …
NVAF) に対してワルファリンで抗凝固療法を施行されていた. 1 年半前に心原性脳塞栓症を発症し …